BRIEF-Arch Biopartners to manufacture drug AB569 with Catalent Inhalation
August 10, 2016 at 08:15 AM EDT
* Engaged Catalent Inhalation, a division of Catalent Pharma Solutions, to begin manufacturing process for drug ab569
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.